Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma or urinary bladder: Cause for concern: Editorial comment

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalJournal of Urology
Volume144
Issue number2 I
StatePublished - Jan 1 1990

ASJC Scopus subject areas

  • Urology

Cite this